Target intelligence / Profile preview

Collagen biosynthesis pathway

Molecular classification
Enzyme, Chaperone, Extracellular matrix protein
01

Overview

Collagen biosynthesis is a complex, multi-step biological process responsible for the production and assembly of collagen fibers, which are the primary structural components of the extracellular matrix (ECM). This pathway involves a series of intracellular steps, including the synthesis of pro-alpha chains and extensive post-translational modifications such as the hydroxylation of proline and lysine residues by enzymes like prolyl 4-hydroxylase (Source: StatPearls, Biochemistry, Collagen Synthesis). Following the formation of the triple helix, procollagen is secreted into the extracellular space where it is cleaved and cross-linked by lysyl oxidase (LOX) to provide tensile strength and stability to tissues (Source: NCBI, Collagen: The Structure, Functions, and Biosynthesis). Dysregulation of this pathway is a central driver of fibrotic diseases, where excessive collagen deposition leads to organ scarring and dysfunction, as well as genetic disorders like Osteogenesis Imperfecta (Source: PubMed, Targeting collagen biosynthesis for the treatment of fibrosis). Therapeutic interventions often target specific enzymes within the pathway or upstream signaling molecules like TGF-beta to modulate collagen production in conditions such as pulmonary fibrosis or liver cirrhosis (Source: Journal of Clinical Investigation, Collagen synthesis and its control).

Other names
Collagen synthesisFibrillogenesisCollagen productionProcollagen biosynthetic process
02

Mechanism of action

Inhibition of post-translational modification enzymes such as prolyl 4-hydroxylase and lysyl oxidase, modulation of TGF-beta signaling to reduce fibroblast activation, and inhibition of collagen cross-linking.

03

Biological functions

Extracellular matrix organizationTissue repairCell adhesionStructural integrityWound healing
04

Disease associations

FibrosisSclerodermaOsteogenesis imperfectaEhlers-Danlos syndromeCancerScurvyCardiovascular disease
05

Safety considerations

Impaired wound healingVascular fragilityConnective tissue disordersBone density lossJoint laxity
06

Interacting drugs

Pirfenidone

5 more in the full profile.

07

Biomarkers

Procollagen type I N-terminal propeptide (PINP)Procollagen type III N-terminal propeptide (PIIINP)C-terminal telopeptide of type I collagen (CTX-I)Hydroxyproline levels

Beyond the preview

Go deeper on Collagen biosynthesis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen biosynthesis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call